PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24858801-4	2014	Moreover, the sensitivity enhancement of oroxylin A was demonstrated by decreasing the expression of CXCR4 at both protein and mRNA levels, via PI3K/Akt/NF-kappaB pathway and triggering the apoptosis pathway in vitro.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	41-51	C-X-C motif chemokine receptor 4	Homo sapiens	101-106	
24858801-6	2014	In conclusion, all these results showed that oroxylin A improved the sensitivity of K562/ADM cells by increasing apoptosis in leukemic cells and decreasing the expression of CXCR4 and PI3K/Akt/NF-kappaB pathway, and probably served as a most promising agent for CML treatment.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	45-55	C-X-C motif chemokine receptor 4	Homo sapiens	174-179	
31024831-6	2019	Moreover, the reverse effect of IM resistance by Oroxylin A was demonstrated by the inhibition of beta-catenin/P-gp pathway via the decrease of CXCR4 in vitro.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	49-59	C-X-C motif chemokine receptor 4	Homo sapiens	144-149	
32373542-0	2020	Retraction: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	12-22	C-X-C motif chemokine receptor 4	Homo sapiens	107-112	
31608242-0	2019	Corrigendum: Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	13-21	C-X-C motif chemokine receptor 4	Homo sapiens	108-113	
31024831-0	2019	Oroxylin a Inhibits the Protection of Bone Marrow Microenvironment on CML Cells Through CXCL12/CXCR4/P-gp Signaling Pathway.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	0-10	C-X-C motif chemokine receptor 4	Homo sapiens	95-100	
31024831-8	2019	In conclusion, all these results showed that Oroxylin A improved the sensitivity of K562 and KU812 cells to IM in BM microenvironment by decreasing the expression of CXCR4 and then inhibiting beta-catenin/P-gp pathway.	5,7-dihydroxy-6-methoxy-2-phenylchromen-4-one	45-55	C-X-C motif chemokine receptor 4	Homo sapiens	166-171